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ABSTRACT 
A series of pyrimidinone and dipyrimidinone derivatives 2a-c, 4a-e and 6a-f has been synthesized via the reaction 
between ethyl 2,2-dicyano-1-aryl(or alkyl)vinylcarbamate derivatives 1a-d and hydrazine derivatives or  diamines. The 
reactivity of compounds 1a-d toward hydrazine is studied. The result is the formation of triazolones 5a-d rather than 
pyrimidinone derivatives. 
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INTRODUCTION 
         Over the years pyrimidinones derivatives have emerged as an interesting class of heterocycles with an 
astonishingly wide range of applications in pharmaceutical chemistry [1-4]. It is of great interest that specifically 
functionalized pyrimidinones may possess specific biological properties. Some are endowed with antiviral activity [5-6], 
antitumor activity [7-8], anti-inflammatory [9], antioxidant [10]. Many synthetic procedures exist for the synthesis of 
pyrimidinones derivatives [11-15]. However, the development of simple, easy and efficient methodologies to get 
pyrimidinones is one of the major aspects in organic synthesis. In fact, the ethyl 2,2-dicyano-1- aryl (or 
alkyl)vinylcarbamate derivatives are valuable intermediates in a variety of synthetic transformations. In the present study, 
we report the synthesis of some new pyrimidinones, dipyrimidinones and triazolones derivatives. 
RESULTS AND DISCUSSION 
         Pyrimidine derivatives 2a-c were synthesized by cyclization, involving the reaction of substrates 1a-c with 




















Table 1: Chemical structure of target compounds 2a-c. 
 Composé R1 R2 Yield % 
2a C6H5 C6H5 63 
2b C6H5-CH2 C6H5 60 
2c iPr C6H5 57 
 
         The prepared compounds were characterized by spectroscopic techniques. The IR spectra showed the presence of 
two NH groups stretching at 3420-3241cm
-1
 and CN group stretching at 2220-2210 cm
-1
.  In 
1
H NMR spectra the most 
significant information was the disappearance of the triplet and the quadruplet of ethoxy groups of the starting reagent 1a-
c.  
         Compounds 2a-c can be used for the synthesis of heterocyclic compounds. For example we have condensed 2b 
with tetraethyl othocarbonate. The result is the formation of 7-benzyl-2-ethoxy-5-oxo-3-phenyl-3,5-dihydro-
[1,2,4]triazolo[1,5-f]pyrimidine-8-carbonitrile 3 (scheme 2).  Further work is in progress to obtain new structures by 





















         Furthermore, the reactivity of 1 towards benzohydrazide and acetohydrazide was also investigated as an alternative 
route to obtain pyrimidinylbezamide derivatives 4a-b and pyrimidinylacetamide derivatives 4c-e (scheme 3). The reaction 
was carried out in ethanol under reflux (benzohydrazide and acetohydrazide are not soluble in chlorobenzene). The 
intracyclization of compounds 4a-e is not observed (scheme 3). 
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Table 2: Chemical structure of target compounds 4a-e. 
Composé R1 R2 Yield % 
4a C6H5 C6H5 68 
4b iPr C6H5 69 
4c C6H5 CH3 72 
4d C6H5-CH2 CH3 52 
4e iPr CH3 62 
 
         The structures of compounds 4a-e are in accordance with their spectroscopic data. These new products were 
assigned by IR, NMR and mass spectroscopy. The IR spectra showed bands (NH), (CN), and (2C=O). In the 
1
HNMR 
spectra of compounds 4c-e we have noticed the appearance of the singlet of methyl groups at around 2ppm.  
         In addition, heating 1a-d with hydrazine hydrate in chlorobenzene furnished trizol-3-one derivatives 5a-d rather than 
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         The reaction products were confirmed on the basis of their spectral data and mass spectroscopy (5a-b). The IR 
spectra of the isolated products showed the absence of cyano groups. It also showed absorption bands due to (NH) and 
(C=O). Besides, the mass spectra displayed the respective [M + H]
 +
 peaks.  
Hydrazine hydrate reacts with its two nucleophilic centers (NH2 groups) but hydrazine derivatives (phenylhydrazine, 
benzohydrazide and acetohydrazide) react with one of their nucleophilic centers (NH2 and not NH).  This may be due to 
the conjugation of NH with carbonyl or phenyl groups.  
         To further explore the synthetic potential of enamine 1, the condensation of 1a-b with diamine (2,7-diam inofluorene, 
orthodianisidine and 1,4-benzenediamine) was investigated. Thus, refluxing ethyl 2,2-dicyano-1-arylvinylcarbamate 































         The structure of compounds 6a-f was proved on the basis of spectral data and mass spectroscopy. The IR spectra 
of 6a-f indicated the presence of NH group stretching at 3328-3132 cm
-1
, CN group stretching at 2207-2210 cm
-1
 and C=O 




HNMR spectra of compounds 6a-b indicated a singlet at δ 3.74-3.79 due to CH2 




In conclusion, in this work we have tested the reactivity of ethyl 2,2-dicyano-1-aryl(or alkyl)vinylcarbamate derivatives 
toward phenylhydrazine, benzohydrazide, acetohydrazide, hydrazine and some diamine (2,7-diaminofluorene, 
orthodianisidine and 1,4-benzenediamine). Results demonstrate that hydrazine and its derivatives react differently to the 
compound 1a-d even though they have the same nucleophilic centre. 
EXPERIMENTAL 
  Melting points are recorded in degrees Celsius on a Kofler apparatus. All reactions were followed by TLC (E. Merck 
Kieselgel 60 F-254), with UV detection at 254 nm.  The IR spectra were recorded in the solid state as KBr discs on a 




C NMR were determined in solution in DMSO-d6 with an AC 
Bruker spectrometer at 300 MHz using TMS as an internal standard. The mass spectra were recorded on an ion trap 
mass spectrometer (Finnigan LCQ Deca XP Max) using electrospray as an ionization source. The purity of all compounds 
was determined by LC-PDA-MS methods and was found to be in the range between 96-99%.  
GENERAL EXPERIMENTAL PROCEDURE 
General procedure for the preparation of 2a-c , 4a-e and 6a-f. 
      To a magnetically stirred solution of the ethyl 2,2-dicyanolvinylcarbamate derivatives 1a-d (1 mmol) in 
chlorobenzene or ethanol (10 mL), the appropriate hydrazine derivatives or diamine (1.2 mmol) were added and the 
reaction mixture stirred  under reflux. The progress of the reaction was monitored by TLC (mobile phase, ethyl acetate: 
dichloromethane; 70/30;v/v). The resulting mixture was allowed to cool at room temperature. The precipitate formed was 
isolated by filtration and washed with diethyl ether to obtain the pure product. 
General procedure for the preparation of 3 
A mixture of 2b (1mmole), tetraethyl othocarbonate (5ml) and few drops of acetic acid was heated under reflux for 24 hr. 
The progress of the reaction was monitored by TLC (mobile phase, diethyl ether: hexane; 60/40;v/v). The solvent was 
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Spectral Data of New Compounds 
6-amino-2-oxo-4-phenyl-1-(phenylamino)-1,2-dihydropyrimidine-5-carbonitrile 2a : Yield  = 63% ; mp =212°C ; IR 




H-NMR (DMSO-d6): δ= 6.88- 7.99 (m, 13H); 
13
C-NMR 
(DMSO-d6): δ =  72.8(C5 ), 118.5 (CN), 153.4(C2) , 160.5(C4), 175.1(C6), 125.4-145.2(Carom). 
6-amino-4-benzyl-2-oxo-1-(phenylamino)-1,2-dihydropyrimidine-5-carbonitrile 2b :Yield = 60% ;mp =178°C ; IR 




H-NMR (DMSO-d6): δ=  3.86 (s, 2H ), 6.62-7.33  (m, 10H), 
8.63 (s,2H, NH2 ), 8.76 (s,1H, NH); 
1
H-NMR (DMSO-d6): 43.4 (CH2), 73.5(C5 ), 116.1 (CN), 153.0(C2) , 160.4(C4), 
174.9(C6), 121.3-146.2(Carom).  
6-amino-4-isopropyl-2-oxo-1-(phenylamino)-1,2-dihydropyrimidine-5-carbonitrile 2c:Yield = 57%; mp =148°C; IR 




H-NMR (DMSO-d6): δ= 1.07 (d, 6H),  2.48 (m, 1H ), 6.63- 
7.23 (m, 5H ), 8.52 (s, 2H, NH2), 8.76 (s, 1H, NH ); 
13
C-NMR (DMSO-d6): δ = 20.7(CH3), 34.9 (CH), 72.3 (C5 ), 115.9 
(CN), 153.3(C2) , 160.4(C4), 181.0(C6), 121.2-146.3(Carom). 
7-benzyl-2-ethoxy-5-oxo-3-phenyl-3,5-dihydro-[1,2,4]triazolo[1,5-f]pyrimidine-8-carbonitrile 3: Yield = 20%;  IR (KBr) 




H-NMR (DMSO-d6): δ= 0.93 (t, 3H),  3.62 (s, 2H ), 4.11 (q, 2H), 7.21- 7.93 (m, 10H ); 
13
C-NMR (DMSO-d6): δ = 13.9 (CH3), 31.7 (CH2), 36.7 (CH2),  74.4 (C8 ), 118.0 (CN), 138.3(C7) , 147.2(C5), 153.0(C2), 
124.0-129.6(Carom).                                                                                                                                                                  
N-(6-amino-5-cyano-2-oxo-4-phenylpyrimidin-1(2H)-yl)benzamide 4a
 
: Yield =68% ; mp =256°C; IR (KBr) ν = 3361- 




H-NMR (DMSO-d6): δ= 7.44 – 7.99 (m ,10H), 9.2 (s, 2H, NH2), 
10.60 (s, 1H, NH); 
13
C-NMR (DMSO-d6): δ = 72.5 (C5), 118.5 (CN), 156.8(C2) , 160.7(C4), 166.9(C6), 171.8 (CO), 125.2-
137.1(Carom).                                                                                                                                                                            
N-(6-amino-5-cyano-4-isopropyl-2-oxopyrimidin-1(2H)-yl)benzamide 4b: Yield =69% ; mp =196°C; IR (KBr) ν = 3348 - 




H-NMR (DMSO-d6): δ= 1.14 (d, 6H), 3.01( m, 1H ), 7.39 – 7.97 
(m ,5H), 8.5 (s, 2H, NH2 ), 11.11 (s, 1H, NH ); 
13
C-NMR (DMSO-d6): δ = 20.8 (CH3), 35.0(CH), 72.3 (C5), 115.7 (CN), 
152.4(C2) , 159.9 (C4), 166.9(C6), 181.5 (CO), 127.5-133.0(Carom). 
N-(6-amino-5-cyano-2-oxo-4-phenylpyrimidin-1(2H)-yl)acetamide 4c: Yield =72% ; mp =248 °C ; IR (KBr) ν = 3373 - 




H-NMR (DMSO-d6): δ= 2.03 (s,3 H), 7.50 – 7.76 (m ,5H), 8.65 
(s, 2H, NH2 ), 10.73 (s, 1H, NH ); 
13
C-NMR (DMSO-d6): δ=72.4 (C5), 116.5 (CN), 151.9(C2) , 160.4 (C4), 168.5(C6), 
171.7 (CO), 128.7-137.2 (Carom). 
N-(6-amino-4-benzyl-5-cyano-2-oxopyrimidin-1(2H)-yl)acetamide 4d: Yield = 52%; mp = 226°C; IR (KBr) ν = 3491- 




H-NMR (DMSO-d6): δ= 1.98 (s, 3H), 3.82 (s, 2H ), 7.24- 7.30 (m, 
5H), 8.58 (s,2H, NH2  ), 10.60 (s, 1H, NH ); 
13
C-NMR (DMSO-d6): δ= 43.4 (CH2), 20.9 (CH3), 72.2 (C5), 116.0 (CN), 
152.5(C2) , 159.7 (C4), 168.4(C6), 170.2 (CO), 127.3-136.9 (Carom). 
N-(6-amino-5-cyano-4-isopropyl-2-oxopyrimidin-1(2H)-yl)acetamide 4e : Yield = 62%; mp =240°C; IR (KBr) ν = 3370 - 




H-NMR (DMSO-d6): δ=  1.11 (d, 6H),  1.99 (s, 3H ), 2.96 ( m, 1H 
), 8.49 (s, 2H, NH2), 10.58 (s, 1H, NH); 
13
C-NMR (DMSO-d6): δ= 20.8(CH3),  34.9(CH), C7 20.9 (CH3), 72.2 (C5), 115.7 
(CN), 152.3(C2) , 158.5 (C4), 159.7(C6), 170.2 (CO), 127.5-133.0 (Carom). 




H-NMR (DMSO-d6): δ=  7.43 – 7.75 (m, 5H), 11.69 ( s, 2H, 2NH );  
13
C-NMR (DMSO-d6): δ= 145.5 (C5), 156.8 (C3), 
125.2-130.3 (Carom); MS-(+)ESI: m/z (%):162 ([M+H]
+
, 100).  
5-p-tolyl-2H-1,2,4-triazol-3(4H)-one 5b: Yield = 60%, mp= 269°C; IR (KBr) ν= 3438–3180 (NH), 1713 (C=O);  1H-NMR: 
(DMSO-d6): δ = 2.34 (s, 3H, CH3), 7.30( d, 2H, J=6.0 ), 7.70( d, 2H, J=6.0 ), 11.65 (s,2H, 2NH); 
13
C-NMR (DMSO-d6): δ =  
20.8 (CH3), 145.1 (C5), 156.3 (C3), 124.3-139.3(Carom); MS-(+)ESI: m/z (%):190 ([M+H]
+
, 100). 





NMR (DMSO-d6) : δ=  3.70 (s, 2H ), 7.21 – 7.32 (m, 5H), 11.21 (s,2H, 2NH);  
13
C-NMR (DMSO-d6): δ= 32.9 (CH2), 146.7 
(C5), 156.7 (C3), 127.2-136.7 (Carom). 




H-NMR (DMSO-d6) : δ=  1.13 (d, 6H),  2.94 ( m, 1H ), 11.32 (s, 2H, 2NH), 
13
C-NMR (DMSO-d6): δ= 20.7 (CH3), 
35.0(CH),  146.3 (C5), 156.8 (C3). 
6-amino-1-(7-(6-amino-5-cyano-2-oxo-4-phenylpyrimidin-1(2H)-yl)-9H-fluoren-2-yl)-2-oxo-4-phenyl-1,2-
dihydropyrimidine-5-carbonitrile 6a: yield = 48%; C35H22N8O2, M=586g.mol
-1
, mp= 294°C; IR (KBr) ν: 3315–3197 




H-NMR: (DMSO-d6): δ = 3.79 (s, 2H, CH2), 6.62–7.84 (m,20H, Ar-H + 2NH2); 
13
C-
NMR (DMSO-d6): δ =  36.8 (CH2), 72.7 (C5), 117.1 (CN), 154.3 (C6), 160.8 (C2), 171.7 (C4), 119.5-145.6(Carom); MS-




dihydropyrimidine-5-carbonitrile 6b: Yield = 53%; C37H26N8O2, M=614g.mol
-1
, mp= 209°C; IR (KBr) ν: 3327–3132 




H-NMR: (DMSO-d6): δ = 2.36 (s, 6H, 2CH3), 3.74 (s, 2H, CH2),  6.62–7.90 (m,18H, 
Ar-H + 2NH2); 
13
C-NMR (DMSO-d6): δ =  21.5 (CH3), 36.8 (CH2), 72.6 (C5), 117.2 (CN), 154.3 (C6), 160.8 (C2), 171.4 
(C4), 120.1-144.6(Carom); MS-(+)ESI: m/z (%):615 ([M+H]
+
, 100).   
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Compound 6c: Yield = 39%; C36H26N8O4, M=634g.mol
-1





H-NMR: (DMSO-d6): δ = 3.95 (s, 6H, 2O-CH3), 7.33–8.35 (m,20H, Ar-H + 2NH2); 
13
C-NMR (DMSO-d6): δ =    
56.0 (O-CH3), 72.0 (C5), 117.1 (CN), 154.8 (C6), 159.9 (C2), 171.9 (C4), 119.5-142.9(Carom); MS-(+)ESI: m/z (%):635 
([M+H]
+
, 100).  
Compound 6d: Yield = 41%; C38H30N8O4, M=662g.mol
-1





H-NMR: (DMSO-d6): δ = 2.41 (s, 6H, 2CH3), 4.02 (s, 6H, 2 O-CH3),7.35–7.79 (m,18H, Ar-H + 2NH2); 
13
C-
NMR (DMSO-d6): δ =  21.5 (CH3), 56.5 (O-CH3), 72.1 (C5), 117.1 (CN), 155.5 (C6), 160.5 (C2), 171.9 (C4), 119.6-




carbonitrile 6e: Yield = 62%; C28H18N8O2, M=498g.mol
-1





H-NMR: (DMSO-d6): δ = 6.49–7.95 (m,18H, Ar-H + 2NH2); 
13
C-NMR (DMSO-d6): δ =  72.8 (C5), 117.1 
(CN), 154.5 (C6), 160.9 (C2), 171.3 (C4), 120.9-137.4(Carom); MS-(+)ESI: m/z (%):499 ([M+H]
+
, 100).  
6-amino-1-(4-(6-amino-5-cyano-2-oxo-4-p-tolylpyrimidin-1(2H)-yl)phenyl)-2-oxo-4-p-tolyl-1,2-dihydro pyrimidine-5-
carbonitrile 6f: Yield = 65%; C30H22N8O2, M=526g.mol
-1





H-NMR: (DMSO-d6): δ = 2.39 (s, 6H, 2CH3), 6.66–7.95 (m,16H, Ar-H + 2NH2); 
13
C-NMR (DMSO-d6): δ = 
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